title: Patentability of Parthenogenic Stem Cells: International Stem Cell Corporation v. Comptroller General of Patents.
abstract: The European Court of Justice (ECJ) has recently issued a ruling in Case C-364/13 International Stem Cell Corporation v. Comptroller General of Patents Designs and Tademarks (Case) that aims at harmonising the patenting practices regarding interpretation of Article 6.2.c of Directive 98/44/EC (Biotech Patent Directive) in respect of patentability of human parthenogenic stem cells (hpSCs). The Case alters the patenting regime for human embryonic stem cell (hESC) applications, by stating that moral restrictions against hESC-patents are only applicable to such cells derived from embryos that had the potential to develop into a human being. Consequently, hpSC-based inventions may be patentable in Europe. This Case represents a leap forward to striking a balance between protecting human dignity and integrity whilst granting patent incentives for biomedical research.
authors.forename: Juli
authors.initials: J
authors.lastname: Mansnérus
mesh_terms: D053595:Embryonic Stem Cells; D005060:Europe; D006801:Humans; D010312:Parthenogenesis; D010330:Patents as Topic / Q000331:legislation & jurisprudence*